Transfusion medicine

Recent Updates

Published: 
Sep 10, 2019
Chapter 7

Background

Originally all plasma fractionation products were derived from pooled human plasma. Increasingly, many plasma proteins are manufactured by biotechnology as recombinant proteins, without need for donated plasma; depending on the plasma protein product, either a recombinant or fractionated product, or both are available in Canada.

Transfusion
Published: 
Aug 8, 2019
Chapter 6

All blood transfused in Canada is collected from volunteer donors. To ensure the safety of the blood products, donors are carefully screened against an extended list of eligibility criteria. In addition, the donated blood is tested to identify the donor’s blood group and to detect blood group antibodies and transfusion-transmissible pathogens. Donor eligibility criteria and testing also benefit the donors by, for example, reducing potential blood donation-related health risks.

Transfusion
Modified on: 
May 21, 2019

We are pleased to provide on a regular basis a Surveillance Report describing infectious disease surveillance that our stakeholders can consult to make evidence-based decisions.

Transfusion

Upcoming Events

When
September 23, 2019 | 8:00AM to September 24, 2019 | 4:30PM
Where

Bethesda, MD

The development and execution of clinical trials that evaluate hemostatic products are impeded by the lack of commonly accepted outcomes by the necessary funding and regulatory agencies. The establishment of clinically relevant outcomes that are widely accepted for patients in clinical trials evaluating hemostatic blood products and therapeutics will enhance the ability to perform high quality clinical trials.

Transfusion
When
September 25, 2019 | 12:00PM to 1:00PM
Where

Webinar

Speaker:

Evan Bloch, M.D.
Associate Professor, Department of Pathology
Associate Director of Transfusion Medicine
Johns Hopkins University School of Medicine

Webinar Objectives:

1)  Overview of parasites associated with blood transfusion.
2)  Explain the impact of parasite infections on blood safety and mitigations.
3)  Highlight the FDA guideline for the industry: Recommendation for Reducing the Risk of Transfusion-Transmitted Babesiosis

Transfusion
When
September 26, 2019 | 12:00PM to 1:00PM
Where

Toronto/Webinar

Presented by:

Dr. Donald Branch
Professor of Medicine and Laboratory Medicine and Pathobiology, University of Toronto
Affiliate Scientist, Division of Experimental Therapeutics, Toronto General Hospital Research Institute
Senior Scientist, Centre for Innovation, Canadian Blood Services

Ms. Jenny Nguyen
Medical Laboratory Technologist, University Health Network
Bsc Hons Biology, McMaster University 

Transfusion

Blog

Modified on: 
Sep 18, 2019

Centre for Innovation scientist Dr. Jason Acker was recently inducted as a Fellow of the Society for Cryobiology, a prestigious international award that recognizes individuals who have had an exemplary impact on the field of cryobiology. Congratulations to Dr. Acker, who received this award over the summer at the Society for Cryobiology’s annual meeting in San Diego.

Organs and Tissues
Stem Cells
Transfusion

Modified on: 
Sep 11, 2019

Always an engaging and informative event, this year’s partnership with the University of British Columbia’s School of Biomedical Engineering meant the Centre for Blood Research’s 2019 Research Day touched on an astonishing array of topics...

Organs and Tissues
Stem Cells
Transfusion

Modified on: 
Sep 5, 2019

On the May 30, an eager group of Canadian Blood Services trainees gathered In Calgary, Alta. for the Centre for Innovation’s Research Trainee Workshop. The attendees spent the day at the Eau Claire donor centre to learn about donor selection criteria, the blood donor experience, and the art of science blogging.

Transfusion